TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases. (Q36360818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Orsolya Szokolóczi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Richárd Schwab

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

István Peták

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Akos Pap

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alex N Eberle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tamás Szüts

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

György Kéril

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

Journal of Receptors and Signal Transduction

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

217-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells

15 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F10799890500464621

Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F10799890500464621

10.1080/10799890500464621

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16393913%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference